May 8, 2017 ... Utts et al v. Bristol-Myers Squibb Company et al, No. 1:2016cv05668 - Document 67 (S.D.N.Y. 2017) case opinion from the Southern District of ...
Jun 27, 2017 ... Ophelia Dubose v. Bristol-Myers Squibb Company et al, No. 3:2017cv00244 - Document 39 (N.D. Cal. 2017) case opinion from the Northern ...
Dec 20, 2016 ... Received grants for clinical research from: Merck & Co., Inc.; ... LLC; Bristol-Myers Squibb Company; Celgene Corporation; Gilead Sciences, ...
Mar 24, 2015 ... Otsuka Pharmaceutical Co., Ltd., et al.,. Plaintiff, v. Sylvia Mathews Burwell, et al. ... Schering-Plough Corp. and Bristol-Myers Squibb Co. ...... confirmed in the e- mail correspondence from Kofi Ansah of FDA to Patrick Guinn.
Mar 20, 2012 ... Original Assignee, Bristol-Myers Squibb Company .... The receptor was initially described in mice (B. Kwon et al., P.N.A.S. USA, ..... (2000); I. Melero et al., Cell Immunol., 190(2):167-72 (1998); B. Guinn et al., ... of CD137 costimulation in graft -vs-host disease, and anti-viral cytolytic T-cell responses.
gated through use of gradual CD3+ cell dose escalation (Peggs et al.,. 2003). 2.3 . .... co-culture of NK cells with the leukemia cell line K562-mb15-41BBL. (Fujisaki et .... et al., 2009). The mAb elotuzumab (HuLuc63, Bristol-Myers Squibb/AbbVie) ..... and renewed interest by the pharmaceutical industry (Guinn et al.,. 2007).
Our results indicate that 4-1BB co-stimulation may significantly improve TIL survival during ... mAb from Bristol Myers Squibb (BMS) currently being tested in clinical trials,. ... BMS-663513 was at 14.9 mg/ml and was stored at 4°C. This Ab was .... The cells were then stained with anti-CD8-Pacific Blue, Annexin V-PE, and ...
Aug 23, 2011 ... Kappos (2012) · Bristol-Myers Squibb Company v. ... Also of counsel were Polaphat Veravanich, O'Melveny & Myers LLP, ..... Compare Guinn v. ..... This principle was reaffirmed by the Supreme Court's opinion in KSR International Co. v. ... Id. (quoting J.A. 6117, John J. Toole et al., A Large Region (&approx ...
Jun 24, 2015 ... Gene transfer of a co-stimulatory ligand to tumor cells renders such a cell line more immunogenic. ... (Azpilikueta A, Agorreta J et al, manuscript in preparation) indicating a more general trend. ..... MJK is a Full time employee in Bristol-Myers Squibb. ..... Guinn BA, DeBenedette MA, Watts TH, Berinstein NL.